Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2086 in Adults With Narcolepsy
NCT07493265Phase 2Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of E2086 in narcolepsy, sponsored by Eisai Co., Ltd.. Started Mar 2026; status: recruiting.
02
Drugs
E2086
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT07493265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07493265.